Incidence of hypogonadism in the four phenotypes.
收藏数据链接：
官方服务：
资源简介：
Incidence of hypogonadism in the four phenotypes.
应用场景：
创建时间：
2022-03-23
相关数据集
Male Hypogonadism Market- by Therapy (Testosterone replacement therapy, Gonadotropin-releasing hormones therapy), by Drug delivery (Injectables, Topical gels, Transdermal patches, Others), by Type (Kallmann syndrome, Klinefelters syndrome, Pituitary disorders, Others) - Global Industry Perspective Comprehensive Analysis and Forecast, 2024 - 2032
Global Male Hypogonadism Market size valued at US$ 3.63 Billion in 2023, set to reach US$ 5.83 Billion by 2032 at a CAGR of about 5.4%.
www.zionmarketresearch.com2024-11-22 更新60
Supplementary Material for: A Novel SEMA3G Mutation in Two Siblings Affected by Syndromic GnRH Deficiency
Introduction: Gonadotropin-releasing hormone (GnRH) deficiency causes hypogonadotropic hypogonadism (HH), a rare genetic disorder that impairs sexual reproduction. HH can be due to defec
DataCite Commons2020-08-25 更新40
Table2_Case report: Novel SIN3A loss-of-function variant as causative for hypogonadotropic hypogonadism in Witteveen–Kolk syndrome.xlsx
Pubertal delay can be due to hypogonadotropic hypogonadism (HH), which may occur in association with anosmia or hyposmia and is known as Kallmann syndrome (OMIM #308700). Recently, hypogonadotropic hy
NIAID Data Ecosystem20
Serum Minerals and Male Age-Related Hypogonadism: Multimodal Evidence Decoding Associations and Intervention Strategies
Supplementary Materials
NIAID Data Ecosystem40
Novel potentially clinically valuable protein markers of androgen activity in humans
Background Testosterone (T) is the main androgen playing a crucial role in regulating the function of both reproductive and non-reproductive organs. Current methods for assessing T levels in humans d
NIAID Data Ecosystem20
